Spinifex Pharmaceuticals is a clinical-stage Australian biotechnology company specialising in the development of products for the treatment of pain.
Data Released at NEURODIAB
Spinifex Pharmaceuticals announces the presentation of new data at the 21st Annual NEURODIAB meeting, where EMA401 is shown to improve nerve and neurovascular function.
Latest News & Events
16TH FEBRUARY 2012 Spinifex Wins a BioSpectrum Editor's Choice Award in the Category of 'BioSpectrum Asia-Pacific Emerging ... More
10TH JANUARY 2012 Spinifex presented at the Biotech Showcase 2012 conference in San Francisco ... More
6TH DECEMBER 2011 Appointment of Spinifex Non-Executive Chairman. ... More